(EMAILWIRE.COM, October 12, 2018 ) According to the new market research report “Cell Line Development Market by Product (Equipment, Media and Reagents), by Source, by type, by Application ( Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research, Drug Discovery) - Analysis & Global Forecast to 2019", published by MarketsandMarkets™, analyzes and studies the major market drivers, threats, opportunities, and challenges.

Don’t miss out on business opportunities in Cell Line Development Market. Speak to our analyst and gain crucial industry insights that will help your business grow: http://bit.ly/2PwTmjz
Early buyers will receive 10% customization on reports.

The cell line development market is highly competitive with a large number of players, including both big and small players, operating in this market. Cell lines are used in many pharmaceutical and biotechnology industries, academic research institutes, and diagnostic laboratories. In order to develop high-yielding and stable cell lines, companies and research institutes are engaged in research activities to develop more efficient technologies for development of cell lines.

The global market is segmented on the basis of product, source, type, application, and geography. The global market, by product is categorized into equipment and media and reagents. The media and reagents segment is further divided into serum, media, and reagents. The reagents market is expected to account for the largest share of the market. However, media is expected to be the fastest-growing segment in the reagents market.

The cell line development market, by type is divided into primary cell lines, continuous cell lines, hybridomas, and recombinant cell lines. Recombinant cell lines accounted for the largest share of the market, by type. However, the primary cell lines segment is expected to grow at the fastest rate in the market, by type.

Based on the source of cell lines, the market is segmented into mammalians, insects, and amphibians. The mammalian segment is the largest and the fastest growing segment of the market, by source.

On the basis of applications, the market is segmented into bioproduction, tissue engineering and regenerative medicine, toxicity testing, research, and drug discovery. In 2014, the bioproduction segment accounted for the largest share of the cell line development application market, as cell lines are extensively used in diagnostics, vaccine production, and manufacturing of recombinant protein therapeutics.

The key factors that are expected to spur this market are increased demand for monoclonal antibodies, rising vaccine production, and use of innovative technologies. However, developing stable and authentic cell lines poses a major challenge for this market. Some of the opportunities for cell line development market are low income countries and increasing risk of pandemics and communicable diseases.

On the basis of geography, this market is classified into four regions, namely, North America, Europe, Asia, and Rest of the World (RoW).

Browse and in-depth TOC on “Cell Line Development Market”
114 - Tables

64 - Figures

225 - Pages

View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/cell-line-development-market-152900899.html

The global cell line development market is expected to reach $3.96 billion by 2019 from $2.2 billion in 2014, and is expected to grow at a CAGR of 12.5% from 2014 to 2019. The market is dominated by North America, followed by Europe, Asia, and Rest of the World (RoW). North America is expected to maintain its leadership position in the market in the coming years.

Some of the major players in the global market include American Type Culture Collection (ATCC) (U.S.), Lonza Group AG (Switzerland), Thermo Fisher Scientific, Inc. (U.S.), GE Healthcare (U.K.), Sigma Aldrich Corporation (U.S.), Selexis SA (Switzerland), European Collection of Cell Cultures (ECACC) (U.K.), Corning, Inc. (U.S.), Wuxi App Tec, Inc. (China), and Sartorious AG (Germany).

Request for Free Sample Report @ http://bit.ly/2QGjetl

Browse Adjacent Markets @ Biotechnology Market Research Reports & Consulting

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:

Mr. Shelly Singh

MarketsandMarkets™ INC.
630 Dundee Road

Suite 430

Northbrook, IL 60062

USA : 1-888-600-6441

Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/cell-line-development-market.asp

Visit Our Website: https://www.marketsandmarkets.com